The present disclosure provides systems and methods for controlling gas-enrichment, e.g., oxygen-enrichment, therapy. One or more sensors and/or one or more imaging systems may be used to measure or determine one or more physiological parameters of the patient. Feedback regarding one or more physiological parameters or microvascular resistance may be provided for titrating or controlling the gas-enrichment therapy.

Described are systems and methods for administration of nitric oxide (NO) with use of left ventricular assists devices (LVADs), as well as systems and methods for monitoring the NO delivery devices and/or the LVAD.

Described are systems and methods for administration of nitric oxide (NO) with use of left ventricular assists devices (LVADs), as well as systems and methods for monitoring the NO delivery devices and/or the LVAD.

A medical device, such as an intra-aortic balloon pump or carrier with an extendable wheel track and handle configured to be removably carried and integrated with a cart. The wheel track is configured to extend upon extension of the handle and to return to its original position upon retraction of the handle.

An extracorporeal cardiac assistance system, comprising a pump being configured to create a fluid flow from a suction line to a pressure line of the system; further comprising a control device configured to control the pump and/or an adjustable flow limiter to provide an adjustable flow rate and/or a pressure, wherein the control device is configured to execute a support mode with a plurality of consecutive support flow rate pulses and/or support pressure pulses interposed on the fluid flow and to execute a weaning mode with a plurality of such pulses, wherein an amount of energy provided to the fluid flow with each pulse is lower in the weaning mode than in the support mode.

An extracorporeal cardiac assistance system, comprising a pump being configured to create a fluid flow from a suction line to a pressure line of the system; further comprising a control device configured to control the pump and/or an adjustable flow limiter to provide an adjustable flow rate and/or a pressure, wherein the control device is configured to execute a support mode with a plurality of consecutive support flow rate pulses and/or support pressure pulses interposed on the fluid flow and to execute a weaning mode with a plurality of such pulses, wherein an amount of energy provided to the fluid flow with each pulse is lower in the weaning mode than in the support mode.

The present invention relates to an implantable device for improving the pump function of the heart of a human patient by applying an external force on the heart muscle, said device comprising at least one pump device comprising: a first part having a first surface, and a second part having a second surface. The first part is displaceable in relation to the second part and said first and second surfaces abut each other, at least partially. The second part exerts, directly or indirectly, force on an external part of said heart muscle.

A catheter pump assembly is provided that includes an elongate body, an elongate flexible shaft disposed in the elongate body, and an impeller coupled with the distal end of the elongate flexible shaft. The drive system includes a drive component, a motor and a tension member. The tension member is coupled with the motor and the drive component and to cause the drive component to rotate, and thereby to cause the impeller to rotate.

A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.

The invention relates to a method for determining a fluid volume flow (1) through an implanted vascular support system (2), comprising the following steps: a) determining a fluid temperature parameter in the region of a cannula (4) of the support system (2), b) operating a heating element (5) which can bring about a change in a fluid temperature in the cannula (4), c) determining the fluid volume flow (1) using at least the fluid temperature parameter or the change thereof and at least one heating element operating parameter or the change thereof. The invention also relates to a vascular support system.